NASDAQ:EPIX
ESSA Pharma Inc. Stock News
$6.43
+0.290 (+4.72%)
At Close: Apr 30, 2024
ESSA Pharma Announces Pricing of Public Offering of Common Shares
01:18am, Wednesday, 29'th Jul 2020
ESSA Pharma Inc. ("ESSA", or the "Company") (Nasdaq: EPIX) (TSX-V: EPI), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today annou
ESSA Pharma Announces Proposed Public Offering of Common Shares
08:01pm, Tuesday, 28'th Jul 2020
ESSA Pharma Inc. ("ESSA", or the "Company") (Nasdaq: EPIX) (TSXV: EPI), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announ
Have Insiders Been Buying ESSA Pharma Inc. (CVE:EPI) Shares?
01:37pm, Friday, 17'th Jul 2020
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...
ESSA Pharma Announces First Patient Dosed in a Phase 1 Clinical Trial of EPI-7386 for Metastatic Castration-Resistant Prostrate Cancer
11:00am, Wednesday, 15'th Jul 2020
HOUSTON and VANCOUVER, BC , July 15, 2020 /CNW/ - ESSA Pharma Inc. (EPIX) (EPI.V), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate canc
ESSA Pharma Presents Therapeutic Potential of EPI-7386 at the 2020 American Association for Cancer Research Virtual Annual Meeting II
Stocks To Watch: Nike, Apple, Ford And Stressed Banks
08:39am, Saturday, 20'th Jun 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Hedge Funds Are Souring On ESSA Pharma Inc. (EPIX)
10:25pm, Thursday, 04'th Jun 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filing
ESSA Pharma to Present at Jefferies Virtual Healthcare Conference
11:00am, Wednesday, 27'th May 2020
ESSA Pharma Inc. (Nasdaq: EPIX; TSX-V: EPI; ) ("ESSA" or the "Company"), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer announced th
EPIX: Additional Preclinical Data Presented at AUA 2020…
09:32am, Wednesday, 27'th May 2020
By David Bautz, PhD NASDAQ:EPIX READ THE FULL EPIX RESEARCH REPORT Business Update New Preclinical Data Presented at AUA 2020 On May 15, 2020, ESSA Pharma Inc. (NASDAQ:EPIX) announced new preclinical
ESSA Pharma Inc. (CVE:EPI): What Does Its Beta Value Mean For Your Portfolio?
12:13pm, Monday, 18'th May 2020
Anyone researching ESSA Pharma Inc. (CVE:EPI) might want to consider the historical volatility of the share price...
ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 2020 Virtual American Urological Association (AUA) Annual Meeting
11:30am, Friday, 15'th May 2020
ESSA Pharma Inc. (Nasdaq: EPIX; TSX-V: EPI), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today presented new preclinical data on
EPIX: FDA Gives OK to Initiate Phase 1 Trial of EPI-7386…
11:25am, Tuesday, 12'th May 2020
By David Bautz, PhD NASDAQ:EPIX READ THE FULL EPIX RESEARCH REPORT Business Update IND Cleared to Start Phase 1 Clinical Trial of EPI-7386 On March 31, 2020, ESSA Pharma Inc. (NASDAQ:EPIX) announced t
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020
09:05pm, Thursday, 07'th May 2020
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs May 1.) * Arcturus Therapeutics Ltd (NASDAQ: ARCT) * AstraZe
ESSA Pharma Announces FDA Allowance of the Clinical Investigation of EPI-7386 in Prostate Cancer
09:45pm, Thursday, 30'th Apr 2020
VANCOUVER and HOUSTON , April 30, 2020 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (Nasdaq: EPIX, TSX-V: EPI), a pharmaceutical company focused on developing novel therapies for the treat
